13F

Stock

Relmada Therapeutics, Inc.

RLMD · held by 2 managers

Reported value

$462K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$83.2K

Price effect on 2 books still in the name

Largest holder

$438K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC146K$438K$78.8KAdded$78.8K
Leonteq Securities AG8K$24K$4.32KAdded$4.32K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.